Houston Voices

Rice Business study finds that a daily routine can foster creativity in the workplace

Having a routine can help foster creativity, a Rice University study found. Getty Images

Think of a routine: your morning workout, walking the dog, making your bed. It's hard to imagine these as creative pursuits. After all, Leonardo da Vinci may have made his bed every morning, but it's probably not what inspired him to paint the Mona Lisa.

So it's no surprise that workplace analysts have long considered routines to be the antithesis of creativity. But it turns out that the relationship between the two is more complementary than previously believed. Scott Sonenshein, a management professor at Rice Business, studied just how this relationship works. What Sonenshein wanted to know was, how can an organization achieve creative outcomes through routine?

For the answer, think of da Vinci again. Certain repetitive aspects of style make his work recognizably his. It's how we can instantly see that The Last Supper, St. John the Baptist and the Mona Lisa are all the work of his hand. In that sense, they are both repeated patterns and feats of genius.

For Sonenshein, some retailers are, in a sense, the da Vincis of suburban America. Sonenshein examined data from a fast-growing retailer that operates a chain of roughly 400 clothing, jewelry, accessory and gift stores across the U.S., and was fascinated to see how it could surprise its customers each season while maintaining a brand image that makes the retailer easily identifiable. Sonenshein realized that the retailer was effectively routinizing creativity.

When he interviewed corporate managers and store employees at the retailer he calls "BoutiqueCo," a pattern emerged. Sonenshein discovered something he calls "familiar novelty" in the way the retailer designs its stores. While most stores use a rigid floor plan for the display of merchandise, BoutiqueCo instead adopts a set of flexible guidelines.

These rules of the road are explicit enough to ensure that each store is readily identifiable as a BoutiqueCo outlet. But because the display rules afford a great deal of flexibility, they allow space for creative employees to come up with their own ideas. If merchandising were a musical score, Sonenshein observed a dynamic that is less like marching band music and more like jazz. Employees are encouraged to riff off of the main themes of the chain to regularly create something unexpected.

Of course, creating novel effects doesn't come naturally to everyone. It takes a certain kind of individual to achieve it, especially in the highly visual area of merchandising. Store managers told Sonenshein that they actively look for employees who are willing to take visual risks and engage creatively while still keeping to the rules of the company road.

Finally, creativity is routinized in the stores' feedback systems. This takes place both among employees, who frequently discuss and even debate their work with each other, and in the more formal setting of managerial feedback. Managers actively encourage creativity, urging employees to put their personalities into the work of the store, to the point where brand identity and individual identity intermingle.

So what does the experience of one outlet tell us about the relationship between creativity and routines? Sonenshein suggests that there is a strong role for personalization of routine tasks in the creative workplace. When employees bring their own preferences to routine performances, it can elevate them from mundane to novel.

Of course, it's unlikely that a window dresser will create the next Mona Lisa while promoting the spring line. Genius like da Vinci's may only come along once in a millennium. But if we put a little soul into our work under the guidance of managers who allow us to riff off of the corporate sheet music, remarkable things become possible.

------

This article originally appeared on Rice Business Wisdom.

Scott Sonenshein is the Henry Gardiner Symonds Professor of Management at Jones Graduate School of Business at Rice University.

Trending News

Building Houston

 
 

A Rice research team is tapping into materials science to better understand Alzheimer’s disease, a UH professor is developing a treatment for hereditary vision loss, and a BCM researcher is looking at stress and brain cancer. Photo by Gustavo Raskosky/Rice University

Research, perhaps now more than ever, is crucial to expanding and growing innovation in Houston — and it's happening across the city right under our noses.

In InnovationMap's latest roundup of research news, three Houston institutions are working on life-saving health care research thanks to new technologies.

Rice University scientists' groundbreaking alzheimer's study

Angel Martí (right) and his co-authors (from left) Utana Umezaki and Zhi Mei Sonia He have published their latest findings on Alzheimer’s disease. Photo by Gustavo Raskosky/Rice University

According to the Centers for Disease Control and Prevention, Alzheimer’s disease will affect nearly 14 million people in the U.S. by 2060. A group of scientists from Rice University are looking into a peptide associated with the disease, and their study was published in Chemical Science.

Angel Martí — a professor of chemistry, bioengineering, and materials science and nanoengineering and faculty director of the Rice Emerging Scholars Program — and his team have developed a new approach using time-resolved spectroscopy and computational chemistry, according to a news release from Rice. The scientists "found experimental evidence of an alternative binding site on amyloid-beta aggregates, opening the door to the development of new therapies for Alzheimer’s and other diseases associated with amyloid deposits."

Amyloid plaque deposits in the brain are a main feature of Alzheimer’s, per Rice.

“Amyloid-beta is a peptide that aggregates in the brains of people that suffer from Alzheimer’s disease, forming these supramolecular nanoscale fibers, or fibrils” says Martí in the release. “Once they grow sufficiently, these fibrils precipitate and form what we call amyloid plaques.

“Understanding how molecules in general bind to amyloid-beta is particularly important not only for developing drugs that will bind with better affinity to its aggregates, but also for figuring out who the other players are that contribute to cerebral tissue toxicity,” he adds.

The National Science Foundation and the family of the late Professor Donald DuPré, a Houston-born Rice alumnus and former professor of chemistry at the University of Louisville, supported the research, which is explained more thoroughly on Rice's website.

University of Houston professor granted $1.6M for gene therapy treatment for rare eye disease

Muna Naash, a professor at UH, is hoping her research can result in treatment for a rare genetic disease that causes vision loss. Photo via UH.edu

A University of Houston researcher is working on a way to restore sight to those suffering from a rare genetic eye disease.

Muna Naash, the John S. Dunn Endowed Professor of biomedical engineering at UH, is expanding a method of gene therapy to potentially treat vision loss in patients with Usher Syndrome Type 2A, or USH2A, a rare genetic disease.

Naash has received a $1.6 million grant from the National Eye Institute to support her work. Mutations of the USH2A gene can include hearing loss from birth and progressive loss of vision, according to a news release from UH. Naash's work is looking at applying gene therapy — the introduction of a normal gene into cells to correct genetic disorders — to treat this genetic disease. There is not currently another treatment for USH2A.

“Our goal is to advance our current intravitreal gene therapy platform consisting of DNA nanoparticles/hyaluronic acid nanospheres to deliver large genes in order to develop safe and effective therapies for visual loss in Usher Syndrome Type 2A,” says Naash. “Developing an effective treatment for USH2A has been challenging due to its large coding sequence (15.8 kb) that has precluded its delivery using standard approaches and the presence of multiple isoforms with functions that are not fully understood."

BCM researcher on the impact of stress

This Baylor researcher is looking at the relationship between stress and brain cancer thanks to a new grant. Photo via Andriy Onufriyenko/Getty Images

Stress can impact the human body in a number of ways — from high blood pressure to hair loss — but one Houston scientist is looking into what happens to bodies in the long term, from age-related neurodegeneration to cancer.

Dr. Steven Boeynaems is assistant professor of molecular and human genetics at Baylor College of Medicine. His lab is located at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and he also is a part of the Therapeutic Innovation Center, the Center for Alzheimer’s and Neurodegenerative Diseases, and the Dan L Duncan Comprehensive Cancer Center at Baylor.

Recently, the Cancer Prevention and Research Institute of Texas, or CPRIT, awarded Boeynaems a grant to continue his work studying how cells and organisms respond to stress.

“Any cell, in nature or in our bodies, during its existence, will have to deal with some conditions that deviate from its ideal environment,” Boeynaems says in a BCM press release. “The key issue that all cells face in such conditions is that they can no longer properly fold their proteins, and that leads to the abnormal clumping of proteins into aggregates. We have seen such aggregates occur in many species and under a variety of stress-related conditions, whether it is in a plant dealing with drought or in a human patient with aging-related Alzheimer’s disease."

Now, thanks to the CPRIT funding, he says his lab will now also venture into studying the role of cellular stress in brain cancer.

“A tumor is a very stressful environment for cells, and cancer cells need to continuously adapt to this stress to survive and/or metastasize,” he says in the release.

“Moreover, the same principles of toxic protein aggregation and protection through protein droplets seem to be at play here as well,” he continues. “We have studied protein droplets not only in humans but also in stress-tolerant organisms such as plants and bacteria for years now. We propose to build and leverage on that knowledge to come up with innovative new treatments for cancer patients.”

Trending News